DJ stent and nephrostomy drainage outcomes for upper urinary tract obstruction and determinative factors for drainage selection

Aim: To compare drainage outcomes from double J stent and percutaneous nephrostomy stent for upper urinary tract obstruction and to research factors determining the stent method to be used. Upper urinary tract obstruction may be caused by ureter and kidney stones internally or by local advanced-stage pelvic organ cancers externally and this may lead to sepsis or obstructive uropathy. It is necessary to drain the kidney immediately before definitive treatment of stone patients and prevent increased morbidity and mortality in cancer patients. Materials and Methods: A total of 213 patients with upper urinary tract obstruction and drainage using double J stent and percutaneous nephrostomy catheter were retrospectively assessed. Demographic, operative-postoperative data and predictive factors for stent selection were assessed.Results: The groups were different in terms of age and gender demographically, as well as disease duration before the procedure, comorbid diseases, causative factors, hydronephrosis degree and stone size (p

PDF

___

1. Radecka E, Magnusson M, Magnusson A. Survival time and period of catheterization in patients treated with percutaneous nephrostomy for urinary obstruction due to malignancy. Accta Radiol 2006;47:328-31.
2. Mertens S, Zeegers AGM, Wertheimer PA, Hendriksz TR, Van Bommel EFH. Efficacy and complications of urinary drainage procedures in idiopathic retroperitoneal fibrosis complicated by extrinsic ureteral obstruction. Int J Urol 2014;21:283-8.
3. Tambo M, Okegawa T, Shishido T, et al. Predictors of septic shock in obstructive acute pyelonephritis.World J Urol 2014;32:803-11.
4. Tambo M, Taguchi S, Nakamura Y, et al. Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis. BMC Urol 2020;20:23.
5. Buonaiuto VA, Marquez I, De Toro I, et al. Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study. BMC İnfectious Diseases 2014;14:639.
6. Preminger GM, Tiselius HG, Assimos DG, et al. Guideline for the management of ureteral calculi. Eur Urol 2007;52:1610-31.
7. Hong JY, Suh SW, Shin J. Clinical significance of urinary obstruction in critically ill patients with urinary tract infections. Medicine 2020;99:1.
8. Pergialiotis V, Bellos I, Thomakos N, et al. Survival outcomes of patients with cervical cancer and accompanying hydronephrosis: a systematic review of the literatüre. Oncology Reviews 2019;13:387.
9. Sinistrero G, Sismondi P, Zola P. Results of treatment uterine cervix cancer by radiotherapy. Radiother Oncol 1988;13:257-65.
10. Zhu Z, Zhao J, Li Y, et al. Prognostic value of preoperative hydronephrosis in patients with bladder cancer undergoing radical cystectomy: A metaanalysis. Plos One 2019;14.
11. Gadduci A, Madgirali A, Facchini V, et al. Percutaneous nephrostomy in patients with advanced or recurrent cervical cancer. Obstet Gyneco 1994;21:71-3.
12. Van Aardt MC, Van Aardt J, Mouton A. Impact of percutaneous nephrostomy in South african women with advanced cervical cancer and obstructive uropathy. South Afr J Gynaecol Oncol 2017;9:6-10.
13. Leibovici D, Cooper A, Lindner A, et al. Ureteral Stents: Morbidity and İmpact on Quality of Life. IMAJ 2005;7:491-4.
14. Betchart P, Zumstein V, Piller A, et al. Prevention and treatment of symptoms associated with indwelling ureteral stents: A systematic review. Int J Urol 2017;24:250-9.
15. M Ahmed, AT Lawal, A Bello, et al. Ultrasound guided percutaneous nephrostomy: experience at Ahmadu Bello University Teaching Hospital, Zaria. Niger J Clin Pract 2017;20:1622-5.
16. Turo R, Horsu S, Broome J, et al. Complications of percutaneous nephrostomy in a district general hospital. Turk J Urol 2018;44:478-83.
17. Fowler JE, Mearse EM, Goldin AR. Percutaneous nephrostomy: technigues, indications, and results. Urology 1975;6:428-34.
18. Carrafiello G, Lagana D, Mangini M, et al. Complications of percutaneous nephrostomy in the treatment of malignant ureteral obstructions: single-centre review. Radiol Med 2006;111:562-71.
19. Kaskarelis IS, Papadaki MG, Malliaraki NE, et al. Piperopolous PN. Complications of percutaneous nephrostomy, percutaneous insertion of ureteral endoprosthesis, and replasment procedures. Cardiovasc Intervent Radiol 2001;24:224-8.
20. Kumar S, Dutt UK, Singh S, Dorairajan LN, et al. Prospective audit of complications after ultrasonography- guided percutaneous nephrostomy for upper urinary tract obstructıon using modified Clavien classification system. Urol Ann 2020;12:31-6.
21. Ahmad İ, Pansota MS, Tariq M, et al. Comparison between double J (DJ) ureteral stenting and percutaneous nephrostomy (PCN) in obstructive uropathy. Pak J Med Sci 2013;29:725-9.
22. Ali MS, Mehmood K, Faiq SM, et al. Frequency of complications in image guided percutaneous nephrostomy. J Pak Med Assoc 2013:63;816.
23. Joshi HB, Stainthorpe A, Keeley FX, et al. İndwelling ureteral stents: evaluation of quality of life to aid outcome analysis. J Endourol 2001;15:151-4.
24. Karim R, Sengupta S, Samanta S, et al. Percutaneous nephrostomy by direct puncture technigue: An observational study. İndian J nephrol 2010;20:84-8.
25. Zachariah GG, Olugbemisola OG, Gerber L, et al. Emergent ureteric stent vs percutaneous nephrostomy for obstructive urolithiasis with sepsis: patterns of use and outcomes from a 15-year experience. BJU international 2013;112:122-8.
26. Pandey S, Sharma D, Sankhwar S, et al. Are there any predictive risk factors for failure of ureteric stent in patients with obstructive urolithiasis with sepsis? Investig Clin Urol 2018;59:371-5.
27. Dagli M, Ramchandani P. Percutaneous nephrostomy: Technical aspects and indications. Semin İntervent Radiol 2011;28:424-37.
28. Lynch JO, Cox A, Rawal B, et al. Bilateral obstruction of bilaterally duplicated collecting systems reguiring upper and lower moiety drainage. Ann R Coll Surg Engl 2016;98:55-8.
29. Rosevaer HM, Kim SP, Wenzler DL, et al. Retograde ureteral stents for extrinsic ureteral obstruction: nine years’ experience at University of Michigan. Urology 2007;70:846-50.
30. Kanou T, Fujiyama C, Nishimura K, et al. Management of extrinsic malignant ureteral obstruction with urinary diversion. Int J Urol 2007;14:689-92.